// App-Quantinova.ai

766 : Control of lung cancer with aspirin-triggered stimulation of resolution

Researchers

Presenter

  • Molly M. Gilligan

Principal Investigators

  • Megan L. Sulciner

  • Yael Gus-Brautbar

  • Sesquile Ramon

  • Romain A. Colas

  • Sui Huang

  • Charles N. Serhan

  • Dipak Panigrahy

Medical Centers

  • Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

  • Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

  • Institute for Systems Biology, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Cytokine

Drug/Treatment

  • Erlotinib hydrochloride

  • Etoposide

  • Etoposide phosphate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved